SR-4835, a CDK12 inhibitor, enhances the antitumor efficacy of sunitinib in human renal cell carcinoma through suppression of the ATR-associated DNA damage response pathway: an in vitro and in vivo studyPo‐Ming Chow, Kuo‐How Huang|Research Square|2026Cited by 0